NPC(SH:600713) Zheng Quan Zhi Xing·2025-07-09 08:09Group 1 - The company, Nanjing Pharmaceutical Co., Ltd., is issuing its second medium-term note for 2024, with a total issuance amount of 1 billion [1] - The bond has a maturity period of 5 years and an interest rate of 2.30%, with the first interest payment scheduled for August 9, 2025, amounting to 23 million [1] - The bond is rated AA+ and is managed by China Merchants Bank Co., Ltd., which also serves as the lead underwriter [1][2] Group 2 - The interest payment process involves transferring funds to the designated account of the interbank market clearing house before the payment date, with adjustments made for public holidays [1] - The company and its board members commit to the accuracy and completeness of the announcement and will fulfill subsequent information disclosure obligations as required [2]